Dr Wilber Sabiiti
Principal Research Fellow
Biography
I am a biomedical scientist with interest in translational research, working on the interface of applied biological science and healthcare provision. My work takes a holistic approach from primary discovery and optimisation in the laboratory to addressing barriers of translating biomedical research innovations into policy and practice. Achieving this kind of work requires interdisciplinary approach and expertise, which I have achieved by bringing together international minds in various research consortia primary between UK and Africa but also continental Europe, Asia and North America. In recent years my group has focused on the development and optimisation of rapid tests for quantification of bacteria responsible for tuberculosis (TB) disease and exacerbation of Chronic Obstructive Pulmonary Disease (COPD). This work has resulted in the tuberculosis Molecular Bacterial Load Assay (TB-MBLA), the first ever fully quantitative test for quantifying patient TB bacterial load and measuring the change of this load as patient responds to treatment. Working with interdisciplinary team of researchers from UK, USA and East Africa, we tackled the biolgical and socioeconomic drivers of antimicrobial resistance (AMR), and the impact of COVID-19 on antibiotics use and risk of AMR rise. Owing to the rise in epidemics of viral origin, my research portifolio has expanded to include molecular diagnostics for viral infections, vaccine development and access in low resource settings. Besides research I teach Introductory Epidemiology, Respiratory infections, and tuberculosis pathology, diagnosis and treatment to Bachelor of Medicine- and Interdisciplinary approaches to solving global health challenges to Master of International development- students. I contribute to advancement of research through guest/academic editorship (Frontiers Cellualar & Infection Microbiology, Frontiers Antibiotics, East African Science, and PLoS Global Public Health) and over 20 peer reviews per year for several academic journals. In addition I am member of fulculties of experts for different funding streams including UKRI Applied Global Health, South Africa Medical Research Council, Africa Research Excellence Fund, Commonwealth Scholarship Commission Academic Adviser panel, NIHR College of Experts for the Global Effort on COVID-19, and Newton Fund Biomedical Sciences. I am Co-Chair Immunology & Diagnostics Working Group of the Coalition for Equitable Research in Low Resource Settings (CERCLE), Co-Chief Investigator Africa Vaccine Research Network (AFRIVAXn), Co-ordinator St ANdrews-Africa Health Research newtork (StAAHR) and a TDR/WHO Antimicrobial resitance Knowledge management consultant.
PhD supervision
- Brenda Nakazibwe
- Tionge Sikwese
Selected publications
-
Open access
Africa’s migratory epidemic of Mpox: implications for continued public health surveillance and control
Wayengera, M., Bosa, H. K., Muttamba, W., Kirenga, B., Sabiiti, W., Kamara, N., Boum, Y., Olu, O. O., Mosoka, F., Tajudeen, R. & Kaseya, J., 25 Mar 2026, (E-pub ahead of print) In: The Lancet Regional Health - Africa. Accepted/in press, p. 1-2 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Open access
A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB)
Mlyuka, H. J., Liyoyo, A., Nyaulingo, B., Mpolya, E., Kaswaga, O. L., Semvua, H., Lwambura, S., McHugh, T. D., Wildner, L., Sabiiti, W., Adegbite, B. R., Nliwasa, M., Khosa, C., Mbelele, P., Mbeya, B., Jeremiah, K., Boeree, M. J., Gillespie, S. H., Sloan, D. J. & Mpagama, S. G. & 1 others, , 25 Feb 2026, In: Trials. 27, p. 1-14 14 p., 182.Research output: Contribution to journal › Article › peer-review
-
Open access
Beyond counting the numbers: focused outbreaks response strategies are needed to control the mpox outbreak in Africa
Olu, O. O., Lubajo, R., Wayengera, M., Sabiiti, W., Muwanguzi, E. N., Maleghemi, S. & Bosa, H. K., 29 Jan 2026, In: One Health Outlook. 8, 1, 7 p., 6.Research output: Contribution to journal › Comment/debate › peer-review
-
Open access
Community perspectives and insights into cancer surveillance, prevention, and research: an engaged participatory approach to cancer epidemiology research in remote areas of Northeastern Uganda
Opito, R., Jatho, A., Sabiiti, W., Akurut, H., Othieno, E., Osuwat, L. O., Mugeere, A., Igulot, P. & Orem, J., 24 Apr 2026, (E-pub ahead of print) In: BMC Cancer.Research output: Contribution to journal › Article › peer-review
-
Open access
Simultaneous measurement of 16S-rRNA and pre-16S-rRNA as a strategy to monitor clinical tuberculosis
Dombay, E., Sabiiti, W., Alferes de Lima Headley, D., Légrády, M. B., van Campen, N., Zweijpfennig, S., Boeree, M. J., Sloan, D. J. & Gillespie, S. H., 8 Apr 2026, In: Frontiers in Antibiotics. 5, 12 p., 1760862.Research output: Contribution to journal › Article › peer-review
-
Training needs assessment and capacity building of clinical trial assessors and ethical reviewers to strengthen regulatory review in Tanzania
Mwamwitwa, K. W., Munishi, C. G., Makoye, P. M., Maganga, A. M., Chambiri, S. M., Nyondo, G. G., Mlugu, E. M., Mwalwisi, Y. H., Oriyo, N., Ally, M. S., Simai, B. O., Sabiiti, W., Mmbaga, B. T., Mloka, D., Ntinginya, N. E., Fimbo, A. M. & Kaale, E. A., 27 Apr 2026, (E-pub ahead of print) In: Therapeutic Innovation & Regulatory Science. p. 1-9 9 p.Research output: Contribution to journal › Article › peer-review
-
Open access
A laboratory-focussed desk review of health systems in Uganda, Kenya, and the UK to respond to current and future pandemics
Muttamba, W., O'Hare, B., Ramsay, A., Saxena, V., Kirenga, B. & Sabiiti, W., 29 Aug 2025, In: Journal of Global Health. 15, p. 1-20 20 p., 04194.Research output: Contribution to journal › Article › peer-review
-
Open access
Antibiotics in tuberculosis treatment: impacts on the respiratory microbiome and the role of optimal dosing
Sabiiti, W., 25 Jul 2025, In: Open Access Government. 47, 1, p. 96-97 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Open access
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB
Koele, S. E., Stoycheva, K., Mtweve, C., Manyama, C., Mpagama, S., Mhimbira, F., Wallis, R., Ntinginya, N. E., Liyoyo, A., Huglin, B., Minja, L. T., Wagnerberger, L., Zumba, T., Noreña, I., Peter, D. D., Beattie, T., Makkan, H., Sloan, D. J., Te Brake, L. & Aarnoutse, R. E. & 9 others, , Aug 2025, In: Journal of Antimicrobial Chemotherapy. 80, 8, p. 2305-2313 9 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Exploring transmission dynamics in epidemiologically linked pulmonary tuberculosis cases and household contacts: a WGS-based investigation
Seid, G., Cabibbe, A. M., Zerihun, B., Alemu, A., Diriba, G., Tadesse, G., Sabiiti, W., Moghaddasi, K., Iannucci, I., Cirillo, D. M., Abdela, S., Mariam, S. H. & Gumi, B., 18 Dec 2025, In: BMC Genomics. 27, 1, p. 1-11 11 p., 82.Research output: Contribution to journal › Article › peer-review